We advised Industry Investment (Teollisuussijoitus) in their investment in BC Platforms AG group. BC Platforms is a world leader in providing powerful genomic data management and analysis solutions to address some of the biggest healthcare challenges today by leveraging the convergence of genomics and healthcare information technologies.
22.5.2017
Finnish Industry Investment – Investment in BC Platforms AG group
Related services
Our team
Latest references
BYG4Lab and Keensight Capital – Acquisition of Finbiosoft
Services Data & Technology, Mergers & Acquisitions, Private Equity & Venture Capital, Tax & Structuring, Life Sciences Industry, Private Equity & Venture Capital Industry, Technology & Communications
Case published 14.3.2024
Keensight Capital – Combination of Biovian and 3P Biopharmaceuticals
Services Private Equity & Venture Capital, Tax & Structuring, Life Sciences Industry
Case published 6.2.2024
OP Finland Infrastructure – EUR 50 million investment in Lounea
Services Environment, Infrastructure & Natural Resources, Private Equity & Venture Capital, Private Equity & Venture Capital Industry, Technology & Communications
Case published 25.1.2024
Newil&Bau – Acquisition of the business of Auratum Asunnot and equity funding
Services Private Equity & Venture Capital, Real Estate
Case published 10.1.2024